drugset / Trial / NCT03469271
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
RandomizedFactorialTriple-blindSupportive care
Summary
This research is intended to begin to explore the impact of inspiratory muscle resistance exercise and/or 1,25(OH)2D3 for improving respiratory muscle strength in cancer patients (subjects).
Timeline
- Start
- 2018-05-25
- Primary completion
- 2020-05-21
- Completion
- 2020-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | 0.25 ug | Oral |